Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics…
Articles by Alejandra Viviescas PhD
AzurRx BioPharma has started dosing patients in a Phase 2 clinical trial assessing its investigational therapy MS1819-SD in…
Viral respiratory tract infections in young children with cystic fibrosis tend to be mild and not require hospitalization, a…
High blood levels of the enzyme alanine aminotransferase (ALT) — a biomarker of liver damage — might indicate a higher…
The Cystic Fibrosis Foundation (CFF) will give up to $15 million to Arcturus Therapeutics to advance the development of an…
Kalydeco (ivacaftor) preserved lung function, improved the nutritional status, and reduced hospital visits and chronic bacterial infections in people with…
The inhaled formulation of broad-spectrum antibiotics such as imipenem/cilastatin is a useful alternative to treat chronic lung bacterial infections…
A case report about a 10-year-old boy suggests that Vertex Pharmaceuticals‘ Kalydeco (ivacaftor) can restore the function…
Vivus recently announced a partnership with HarborPath Direct to facilitate access to Pancreaze (pancrelipase) for eligible patients…
The case report of a cystic fibrosis (CF) patient suggests that phages — viruses that naturally infect and kill…